3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Interventions
Etoposide
3
Carboplatin
3
tremelimumab
2
durvalumab
2
atezolizumab
2
PM 01183
2
sacituzumab govitecan
1
pembrolizumab
1
amrubicin
1
Topotecan
1
Cisplatin
1
AMG 757
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Small Cell Lung Carcinoma
×
amrubicin
×
Clear all
NCT05740566
2026-01-05
DeLLphi-304
Amgen
Phase 3
Active not recruiting
509 enrolled
11 charts
1 FDA